Alternatives to Suvoda

Castor offers an intuitive and comprehensive platform for managing clinical trial data, focusing on electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). The platform is optimized for decentralized trials, providing seamless tools for remote patient engagement and data collection. With real-time reporting, Castor helps researchers track trial progress and make data-driven decisions. The solution ensures compliance with industry regulations such as HIPAA, GDPR, and 21 CFR Part 11, making it ideal for life sciences organizations looking to enhance trial efficiency while maintaining high data integrity.

Medrio's Electronic Data Capture (EDC) platform and complimenting eClinical solutions such as ePRO, RTSM, eConsent, and Direct Data Capture (DDC) have been trusted by major pharmaceutical, biotech, CRO, animal health, medical device, and diagnostic companies since 2005. We are known for our easy-to-use solutions, delivering speed and simplicity to clinical trials of all phases, sizes, and complexities. Medrio users can build their databases in an average of 2.8 weeks with no programming required, make mid-study changes with just a few clicks of a mouse, and much more. From bolt-on capabilities to full-service offerings, Medrio offers flexible, modular solutions that give our customers exactly what they need – and none of what they don’t. Our innovative software, as well as the robust and flexible training and support resources we provide our customers, have earned us a 98% customer satisfaction rating.

ClinCapture's mission is to create software that saves lives. ClinCapture's technology reduces the cost of clinical trials. It streamlines data capture and protects patient privacy. Clincapture is a platform that facilitates the evaluation and development drugs, biologics and devices that have the potential to treat a wide variety of medical conditions or diseases.

OpenClinica is a leading provider of clinical data management software solutions. OpenClinica provides powerful tools to ensure that clinical trials are compliant and efficient. OpenClinica Enterprise, OpenClinica Participate and OpenClinica Randomize are the core products. OpenClinica is a powerful clinical trial platform that offers a wide range of tools for data collection, patient engagement, and study management. From electronic data capture (EDC) and eConsent to patient recruitment and real-time reporting, OpenClinica’s solutions automate and simplify the clinical trial process. With features like EHR-to-EDC integration and advanced reporting dashboards, the platform improves data accuracy, reduces delays, and enhances compliance. OpenClinica has been used in over 15,000 clinical studies, providing support for organizations around the globe, including government agencies and pharmaceutical companies, to conduct trials with confidence.

Signant Health operates as a worldwide leader in evidence generation, striving to transform the landscape of clinical trials by connecting with patients in their environments and rethinking the route to validation. Their extensive range of clinical technology solutions includes electronic Clinical Outcome Assessments (eCOA), Electronic Data Capture (EDC), electronic clinician evaluations, and a cohesive eClinical platform. Additionally, they offer patient engagement solutions featuring a user-friendly app, eConsent for informed consent processes, and telemedicine functionalities. Furthermore, Signant Health delivers clinical data and analytics services, which include COA data analysis as well as the aggregation and interpretation of data. With a rich history spanning over three decades, they have played an instrumental role in supporting numerous trials and have been pivotal in hundreds of drug approvals, establishing themselves as a reliable ally for sponsors and CROs eager to provide high-quality data for informed trial decisions and regulatory submissions. Their commitment to innovation continues to shape the future of clinical research.

At Komodo Health, we integrate an extensive understanding of patient interactions with cutting-edge algorithms and years of clinical knowledge to create our Healthcare Map, which offers the most accurate representation of the U.S. healthcare landscape. This Healthcare Map serves as the backbone for our comprehensive suite of software solutions, designed to help you provide exceptional value to your customers, colleagues, and patients alike. Relying solely on traditional scholarly data for strategic planning is now outdated. Our Aperture platform has been meticulously crafted to deliver unparalleled insights into clinical leadership and influence, enabling improvements in care standards where they are needed most—whether that involves the most referenced author, a prominent social media influencer, or the physician with the highest patient volume. Moreover, conventional open/sampled prescription and patient-level data often overlook critical patterns that are essential for accurately identifying individuals with complex care needs or uncommon medical conditions. By addressing these gaps, we aim to enhance patient outcomes and streamline healthcare delivery.

Zelta is a cloud-powered platform for unified clinical data management and acquisition, designed to streamline and enhance clinical trial processes. Its modular architecture adapts to the unique demands of each study, enabling faster and more efficient outcomes. With capabilities such as electronic data capture, clinical operations management—including randomization and trial supply tracking—clinical trial management, and electronic trial master file functionality, Zelta supports comprehensive study oversight. It also enhances patient and provider engagement with electronic clinical outcome assessments and e-consent solutions. Built for studies across all phases, therapeutic areas, and global regions, Zelta offers an intuitive user experience with secure single sign-on access from anywhere. Its flexible and scalable design allows for seamless customization and integration with both native and third-party technologies, ensuring adaptability to diverse research needs.

Mahalo Health is an integrated digital health platform aimed at expediting the creation of patient-focused digital health solutions and clinical trials. By providing a variety of prebuilt modules, Mahalo facilitates the swift launch of customizable white-label applications that cater to particular therapeutic fields. The platform boasts comprehensive data capabilities, featuring a predictive health engine for forecasting diseases and diagnoses, a behavior modification engine to encourage beneficial patient behaviors, and a notification system that ensures timely communication through push notifications, SMS, or emails. Committed to maintaining high security and compliance standards, Mahalo follows regulations such as HIPAA, GCP, ISO27001, and GDPR. Its extensive range of services encompasses multiple therapeutic areas, including diabetes, cognitive health, cardiovascular issues, musculoskeletal conditions, mental health, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Additionally, Mahalo Health empowers healthcare providers with tools to enhance patient engagement and outcomes through its innovative digital solutions.

Clinion eCOA allows you to conduct decentralised clinical trials, with patients participating remotely. Clinion eCOA allows study participant to report their health from their home using their smartphone. This allows clinicians to monitor patients in real time. Clinion eCOA integrates seamlessly with Clinion EDC. Trial participants can input daily outcomes directly. This eliminates data duplication and transcription errors, and provides clinicians with a real time view of patient progress. Multilingual forms are supported by the eCOA app, which makes it easier for patients to engage and provides cleaner data. The eCOA app's decentralised nature allows for faster and wider patient recruitment.

Secure and user friendly cloud-based EDC platform for managing clinical trials and studies of all sizes and complexities: ePRO, eConsent, eCOA, eSource, PROMs, PREMs, functional health assessments and participant education/engagement.

At Clinipace, we provide an unparalleled level of collaboration and control that far exceeds what is typically available in conventional CRO settings. Our mission is to effectively guide you through the complexities of your clinical development program. As a global, full-service contract research organization, we prioritize a personalized approach to clinical research. We emphasize flexibility and collaboration, complemented by our regulatory expertise and leadership in various therapeutic areas. Our goal is to transform the landscape of clinical research across numerous fields, including oncology, rare diseases, gastroenterology, nephrology, and women's health. By integrating cutting-edge technology and an adaptive mindset, Clinipace is dedicated to shaping the future of drug development and enhancing healthcare outcomes. Our commitment to innovative solutions ensures that we remain at the forefront of industry advancements.

Modern Interactive Response Technology (IRT) systems are becoming more intricate. The significance of flexible and customizable IRT cannot be overstated, as this technology serves as the primary source for essential data, including recruitment metrics, clinical trial attrition rates, patient attendance, and more. It is vital to select a platform that is intuitive, optimized for mobile use, and all-encompassing—underpinned by high standards of quality, adaptability, and expertise. Embrace a partnership that offers profound therapeutic knowledge tailored to the contemporary risk-based eClinical landscape. By merging advanced technology with specialized knowledge and a dedication to exceptional service, we enhance clinical trials to achieve favorable patient results. Our extensive understanding of clinical processes and supply chain dynamics fosters innovation, granting clients greater control over their Randomization and Trial Supply Management (RTSM) protocols. Our cutting-edge tools elevate quality assurance, improve site productivity, and enhance patient adherence significantly. Furthermore, our IRT platform is adaptable enough to cater to a wide array of studies, with the capability for full validation and deployment in just 30 days, ensuring efficiency in clinical trial operations. This swift implementation can lead to more timely data collection and improved overall trial management.

Clinical One RTSM is capable of accommodating various randomization strategies, ranging from the most straightforward to highly intricate studies, all without requiring any programming or coding, which consequently reduces the duration of user acceptance testing. You can take charge of your study with self-service configurations, allowing you to develop a study in just a matter of days rather than weeks. Additionally, you can assess the drug inventory status and make real-time adjustments without needing to consult the vendor, thereby avoiding unnecessary costs and change requests. By implementing changes swiftly, you can eliminate expenses associated with change requests and prevent delays, enabling you to launch your studies almost instantaneously. This platform stands out as the only one that genuinely integrates individuals, processes, and data to streamline and expedite the future of clinical trials. Moreover, the inclusion of virtual components in clinical trials enhances patient engagement and significantly elevates the quality of trial data. To keep pace with the rapidly evolving landscape, it is essential to adopt transformative digital strategies that facilitate quicker study initiations, harmonize data from diverse sources, and optimize workflow efficiency. Such advancements are pivotal for the successful execution of modern clinical research initiatives.

Clinion RTSM makes it easy to manage clinical trial supply and patient randomization by using Interactive Response Technologies (IWRS). The Inventory module, which integrates with the Clinion RTSM Software's Randomization module, allows you to implement simple or complex randomization strategies according to protocol specifications. Clinion has one of the best integrated EDC/RTSM platforms available in the industry. Site users can perform Randomization, drug allotment, returns, and re-allotment without having to log in to two systems or worry too much about reconciliation Our predictable and affordable pricing model allows you to lower the cost of RTSM ownership while not sacrificing quality or functionality. You can gain more by integrating EDC and RTSM modules

Enhance the quality of your evidence with superior electronic Patient-Reported Outcomes (ePRO) and electronic Clinical Reported Outcomes (eClinRO). These Electronic Clinical Outcome Assessments, known as eCOA, evaluate patients' feelings and functionality during clinical trials effectively. By collecting clinical data in an electronic format, you can ensure that the data from your patients is not only high-quality but also in compliance with regulatory standards. In essence, eCOA eliminates the challenges related to paper diaries, such as issues with readability, transcription mistakes, and discrepancies in data. Furthermore, the FDA advocates for the use of ePRO. This involves patients providing insights into their health through various questionnaires or assessments, which may include evaluations of quality of life or activity levels. Clinician-reported outcomes, on the other hand, involve health assessments made by a clinician, with examples such as physical examinations like PASI. Additionally, performance outcomes gauge a patient's ability to complete specific tasks, such as performing a timed activity, thereby offering a comprehensive view of their health status. Ultimately, the transition to eCOA and its associated methods signifies a move towards more reliable and efficient clinical trial processes.

AssisTek stands out as a frontrunner in cutting-edge clinical technology solutions tailored for clinical research, providing specialized software that optimizes and improves the process of gathering patient data. With a legacy of over 25 years, the company has successfully facilitated more than 800 clinical research trials spanning 46 therapeutic areas, which include upwards of 500 multinational Phase I–IV clinical trials. Their electronic Clinical Outcome Assessment (eCOA) solutions boast scalability, customization, and efficiency, backed by a reliable cloud-based technology platform. Among their extensive product offerings are the TEK eCOA Tablet, which accommodates any questionnaire utilized in clinical trials, TEK eDiary, enabling the collection of patient-reported outcomes from home, TEK Configurator for comprehensive project development in clinical trials, and TEK Study Portal, which consolidates eClinical tracking, training, and reporting into one convenient location. AssisTek's innovative systems and services have established them as the preferred partner for data collection and analytics, winning the trust of both patients and healthcare professionals alike. As they continue to evolve, AssisTek remains committed to enhancing the efficiency and accuracy of clinical research methodologies.

Medable offers an innovative software solution designed for the research and execution of clinical trials via a decentralized platform. This technology is focused on actively engaging patients remotely to ensure the collection of the most accurate results. Additionally, patients can conveniently provide their consent for digital assessments from a distance, and the platform is tailored to comply with local languages and regulatory requirements. Optimize the decentralization of your protocol with our adaptable, modular digital and decentralized clinical trial (DCT) platform. Facilitate extensive remote screening on a global scale and achieve your enrollment goals more swiftly. Create any type of screening assessment to fit your needs. Enhance the clarity of consent documents with responsive designs suitable for web and mobile devices. Deliver remote eConsent experiences to patients that rival popular consumer digital interfaces. With the capability to adapt to local regulations and languages, we offer global flexibility that accommodates diverse needs. By engaging patients and alleviating the challenges associated with travel and time constraints of on-site visits, you can significantly enhance patient access and involvement in the study. Ultimately, this approach not only streamlines the clinical research process but also prioritizes patient convenience and participation.

Dacima Clinical Suite, the most advanced web-based solution, combines electronic data capture (EDC), medical data management software (CDMS) and clinical trial management software into one platform. Dacima Clinical Suite is designed for clinical trials, epidemiological studies, web randomization, ePRO, surveys, and patient registers. Dacima Clinical Suite comprises three core modules: the Manager (Administrator), Designer Module, and the Data Entry Module.

Our clinical trials management platform is designed to accommodate nearly any type of controlled clinical trial, including those that are randomized, and offers a variety of randomization algorithms. This software can be effortlessly set up for both paper Clinical Report Forms (CRFs) and electronic CRFs (eCRFs). It is capable of capturing data in numerous formats and methods, applying specific guidelines you establish to ensure data integrity and quality control. The system facilitates direct Electronic Data Capture (EDC) through eCRFs or allows for the printing of paper CRFs that can later be input into the platform. Additionally, users can upload various media such as images, audio, video, and documents like consent forms, with the only limitation being the available storage capacity. The system supports Double Data Entry and features comprehensive exception reporting. Moreover, it includes a functionality to lock records after they have been verified, ensuring that no further alterations can be made. This robust capability enhances the overall integrity of the data collected throughout the trial process.

The Medidata Clinical Cloud represents our innovative platform designed to revolutionize the clinical trial journey for patients, sponsors, CROs, and research institutions. As the sole comprehensive technology solution focused exclusively on clinical research, the Medidata Clinical Cloud addresses the entire research spectrum from inception to completion. Our platform enables organizations in the life sciences and medical device sectors to reduce development expenses, manage risks effectively, and expedite the introduction of treatments and devices to the marketplace. Whatever selection you make for your clinical trial initiatives, you will benefit from the capabilities of the Medidata Clinical Cloud. At Medidata, we are at the forefront of the digital evolution in clinical research. With the power of artificial intelligence, machine learning, and sophisticated analytics, our platform connects researchers, study coordinators, investigators, and patients, thereby hastening the research process. Additionally, it provides a regulatory-compliant, patient-friendly electronic informed consent solution for clinical trials, ensuring a smoother experience for all parties involved. This integration of advanced technology not only streamlines operations but also enhances the overall quality of clinical research.

Clin'form is an adaptable and powerful electronic Clinical Outcome Assessment (eCOA) platform that aims to simplify clinical trials for both patients and research sites, improve data integrity, and speed up processes for research teams. Its versatility allows it to be used across various protocols and demographics, making it suitable for any type of questionnaire—including Patient-Reported Outcomes (PRO), Observer-Reported Outcomes (ObsRO), Clinician-Reported Outcomes (ClinRO), and diaries—while catering to individuals of all ages, from children to the elderly. The platform is designed to handle diverse population sizes, effectively managing studies that involve anywhere from a small group to over 10,000 participants spread across multiple regions worldwide. Clin'form integrates smoothly with other clinical systems to provide an efficient workflow, supporting various data collection methods such as dedicated tablets or smartphones, the patient's personal device, web access on any browser, and in-person interviews. Noteworthy features include an integrated tele-visit option to accommodate unexpected changes and patient engagement tools that promote high levels of compliance. Additionally, Clin'form's user-friendly interface ensures that both researchers and participants can easily navigate the platform, making the clinical trial experience more streamlined and effective.

Streamline your clinical studies with Clinvigilant, your global cost-effective eClinical tools provider for CROs, Pharma, Biotech, Nutraceuticals and Academic organizations in clinical and post-marketing stages. Most of our clients choose and stay with us for thanks to our: ♦ Fast EDC set-up (less than 4 weeks). ♦ Cost-effectiveness. ♦ 3rd party integrations (including legacy systems). Our cloud-based suite (Microsoft Azure) is HIPAA, ICH-GCP, GDPR & 21 CFR part 11 compliant and we have been audited by the FDA, EMA and MHRA. The Clinvigilant eClinical suite includes: EDC, CTMS, eCRF, eTMF, eSource, IWRS, ePRO, eConsent and eCOA. Just pick the tools that you need and we will integrate them within your existing software ecosystem. Every interaction and data exchange creates Audit Trails, which provide compliant real-time data visibility across all relevant roles. Our products are modular, highly customizable, and available on the web, iPad, and Mobile App for both Android and iOS. We also support Patient's Own Device (BYOD) and interface with Devices and Wearables. Clinvigilant💊, your one-stop🌐solutions provider for clinical trials☁️ .

Uncover the most cutting-edge methods in the realm of clinical and patient-reported outcomes data. Our comprehensive solution transcends mere data entry, facilitating a genuinely patient-focused research experience. While our eCOA software is deeply rooted in principles of behavioral science, it has also been designed specifically by healthcare professionals to align with the needs of both sites and sponsors. By emphasizing personal identity, motivational intervals, and significant objectives, we stand out from other eCOA solutions. The Datacubed app features a user-friendly interface that allows participants to quickly engage with what truly matters. It has been highlighted that gathering data is now more straightforward than ever, thanks to our adaptable, user-friendly, and interactive application. As the need for flexibility in trial design continues to grow, we provide versatile data collection options that can be executed in person, remotely, or as a hybrid approach, catering to the diverse requirements of traditional, hybrid, and virtual clinical trials. This adaptability ensures that researchers can effectively capture the most relevant data, regardless of the study format.

IVR Clinical Concepts is a company that focuses on offering technology for virtual clinical trials and solutions for patient engagement. Their products feature electronic patient-reported outcomes and patient diaries, which are designed to enhance data quality by minimizing errors, thereby shortening timelines and reducing overall costs. Furthermore, they provide comprehensive patient recruitment and outreach services that emphasize outreach, pre-screening, and the collection of real-time data. The solutions for subject screening, registration, and randomization are characterized as modular, tailored, adaptable, and customizable. In addition to these services, IVRCC also delivers clinical trial material management solutions aimed at lightening the workload while ensuring greater control, along with eClinical integration services that work to unify data seamlessly. Their chart review services offer insights based on real-world data and clinical experiences. By prioritizing custom, modular, and adaptable solutions, IVRCC strives to enhance the patient experience and maximize the success rates of clinical trials. This commitment to innovation positions IVRCC as a leader in the industry, dedicated to improving the efficacy of clinical research.

Koneksa stands out as a prominent digital biomarker firm catering to the pharmaceutical and biotechnology sectors, focusing on the creation, testing, and validation of digital biomarkers that assist clients in assessing how treatments affect patients. Established in 2013, Koneksa delivers comprehensive remote clinical trial support by integrating digital health technologies, therapeutic knowledge, and swift, user-friendly remote data gathering to enhance understanding of patient health outcomes. Their innovative and validated data algorithms are designed for immediate use in treatment development initiatives, facilitating the detection of signals more rapidly than conventional methods. The company's cloud-based Software as a Service (SaaS) platform enables real-time integration of multiple endpoints, providing instant access to data and supporting informed, cost-effective decision-making early in the trial process. Additionally, this platform’s capability to gather extensive remote data at higher frequencies presents opportunities for obtaining ecologically valid measures, which can lead to a reduction in sample size while maintaining the integrity of the research. By continuously evolving their tools and methodologies, Koneksa aims to redefine how clinical trials are conducted in the modern age.

Jeeva's patent-pending modular system is built on the most powerful cloud platform. One login from any browser-enabled device can be used to remotely screen patients, educate, enroll, send SMS, email and generate evidence including electronic patient-reported outcomes. They are tired of waiting for patient recruitment and retention to happen. It is crucial to provide sufficient evidence of safety and efficacy for investigational new medicines in order to receive regulatory agency approval. Jeeva is a great tool for saving time and money for patients, biopharma sponsors, and long-term follow up studies for gene therapy.

TrialPoint™ electronic data capture (EDC) is highly adaptable and user-friendly, earning the approval of coordinators everywhere. Our skilled data managers specialize in transforming clinical protocols into accessible metadata dictionaries, ensuring that TrialPoint™ is tailored to your needs rather than hindering your processes. The platform is capable of accommodating any randomization string, media uploads, or coding dictionaries, and it has the functionality to obscure treatment assignments from users. To enhance timely data collection, the system proactively determines visit windows and dispatches alerts and reminders, helping to keep the entire team aligned and on track. In the current landscape, incorporating patient-reported health outcomes and quality of life questionnaires is common in clinical trials, often leading to protocol adherence challenges. Explore TrialPoint's electronic patient-reported outcomes (ePRO) module, which can be customized to accommodate any quality of life questionnaire or patient diary, providing a seamless experience for participants. Ultimately, this flexibility not only facilitates compliance but also enhances the overall quality of the data collected in clinical trials.

The TCS ADD platform significantly enhances the speed at which pharmaceutical companies can bring products to market by streamlining the entire clinical research and development process, ultimately leading to more agile and secure clinical trials. By fostering digital ecosystems and simplifying the intricacies of data management, TCS ADD facilitates quicker access to innovative and effective medications for patients. This platform utilizes the TCS Decision FabricTM, an advanced cognitive artificial intelligence engine, alongside smart analytics and the Internet of Things, delivering exceptional business advantages to the pharmaceutical sector. It serves as a comprehensive, metadata-driven solution designed to uphold industry standards and sponsor requirements in clinical trials. Furthermore, this data science-oriented platform employs artificial intelligence and machine learning technologies to expedite decision-making, accelerate study initiation, and implement targeted interventions. By digitizing the entire supply chain management of clinical trials while prioritizing patient safety, this solution not only improves overall effectiveness but also enhances the patient experience throughout the trial process. Ultimately, TCS ADD represents a transformative approach to clinical trial management that aligns with the evolving needs of healthcare.

Our leading solution for managing patient randomization and trial supplies is available in various formats, making it the most adaptable and customizable Interactive Response Technology on the market. Whether you're conducting Phase I or Phase IV trials, and regardless of whether your study design is straightforward or involves complex adaptive methodologies, IXRS®3 is equipped to handle any combination of study goals. Additionally, you will benefit from a dedicated team of biostatisticians and integration specialists who are available around the clock to provide support. The functions intended for site users streamline processes that are typically vulnerable to human mistakes, allowing them to correct data independently without needing to contact a Help Desk or worry about compliance issues. Instead of sifting through numerous pages of specifications and legal jargon, users can access clear visual tools that enhance understanding. Furthermore, you can monitor and respond to each development stage of the software build, which helps to prevent unexpected issues during delivery, ensuring a smoother trial experience. This comprehensive approach not only facilitates efficiency but also empowers users with greater control over their trial processes.

Lindus Health is transforming the landscape of clinical trials by providing an all-encompassing solution that yields quicker and more dependable outcomes. Our holistic methodology combines full-service CRO functions, operational site management, and cutting-edge technology, enhancing every facet of your study from initial design to final data delivery. Utilizing our nimble in-house technology, we accelerate the setup of sites and the recruitment of patients, tapping into a vast pool of over 30 million electronic health records to speed up enrollment. Our pricing model, which operates on fixed milestones and pay-on-results, aligns incentives effectively, removing the risk of unforeseen expenses and delays. With an impressive average satisfaction rating of 9.7 out of 10, our dedicated and experienced clinical operations team is committed to achieving excellence at every stage. Lindus Health has quickly broadened its global footprint, successfully conducting more than 91 trials across diverse therapeutic areas, such as metabolic health, women's health, diagnostics, and medical devices, all while maintaining a focus on innovation and quality in clinical research. This relentless pursuit of efficiency and reliability makes Lindus Health a leader in the industry.

5thPort serves as a comprehensive digital platform for patient education, engagement, and electronic consent, applicable in various settings including individual medical practices, hospitals, health systems, and clinical research environments. The platform employs high-quality multimedia resources and a teach-back method to effectively educate patients and their caregivers about their diagnoses, treatment plans, and the associated risks and benefits of proposed procedures. Once patients are adequately informed, the digital eConsent feature fosters a more meaningful dialogue with healthcare providers. By utilizing 5thPort, users can expect to achieve notable outcomes including: 1. Saving 15 to 20 minutes during consultations without any extra effort, 2. Improving the overall patient experience, 3. Alleviating patient anxiety on the day of their visit, 4. Encouraging patients to take an active role in discussions about their healthcare with providers, 5. Mitigating nurse burnout, leading to a more efficient and harmonious healthcare environment. In essence, 5thPort not only streamlines the consent process but also enhances the overall quality of care delivered to patients.

Replior is a pioneering company specializing in software solutions for clinical trials, featuring an integrated platform that encompasses EDC, eConsent, ePRO, and Virtual Visits to enhance trial execution. Our comprehensive system, known as Trial Online, facilitates the seamless collection and management of data from investigators, participants, and wearable devices in an efficient manner. It is designed to accommodate decentralized clinical trials (DCT), allowing for flexibility with site visits, remote interactions, or a combination of both. Our journey commenced two decades ago when we were approached to create an online CRF service for a major pharmaceutical firm, marking our transition from an IT operations provider to a dedicated software developer for clinical data collection. Over the years, we have expanded our offerings to include a complete suite of data collection services, while our IT operations are expertly managed by our highly qualified sister company, Complior. As we continue to innovate, our commitment to enhancing clinical trial processes remains at the forefront of our mission.

AcceleTrial™ eliminates uncertainties in identifying and activating clinical trial sites. Our Study Start-up Management System (SSMS) relies on objective data rather than self-reported information. With AcceleTrial™, you gain access to a comprehensive database of thousands of globally ranked and indexed sites, evaluated based on their specific therapeutic expertise, clinical trial experience, and patient data. This system allows for an objective pairing of the most suitable sites worldwide with the relevant data on expertise, experience, and patient demographics for your clinical trials. You can swiftly engage the right sites to commence patient enrollment through AcceleTrial™'s automated “push and pull” functionality, available in multiple languages. The platform simplifies the process of gathering necessary documents with pre-filled templates and enables real-time tracking of activities. You can begin utilizing the system immediately, as it is a cloud-based solution that requires minimal IT infrastructure or training. Moreover, AcceleTrial™ can be seamlessly integrated with CTMS or other existing clinical trial management systems for enhanced efficiency. This ensures a streamlined approach to clinical trial management, allowing researchers to focus on their core objectives.

ClinOne serves as a comprehensive platform that enhances connectivity and empowerment for participants, caregivers, and clinical trial sites by providing essential tools for trial awareness, consent management, and fostering participant engagement and retention, all supported by robust data analytics and standardized interoperability. Among its many features, Site Hub acts as a centralized resource for trial sites to access vital information, including criteria for participant inclusion and exclusion, site resources, and a streamlined systems landing page equipped with single sign-on capabilities and community engagement options. The Connect module further enriches the experience with features like Sponsor & Monitor Hub, trial awareness initiatives, a healthcare provider community, site selection processes, and data addressing diversity, equity, and inclusion. Meanwhile, the Inform module focuses on facilitating consent management and education through eConsent with eSignature options, as well as offering data insights, tele-visit functionalities, and avenues for community collaboration. Additionally, the Empower module enhances the overall trial experience with services such as transportation management, monitoring medication adherence, and providing a dedicated portal for care partners and caregivers, ensuring a holistic approach to participant support throughout the clinical trial journey.

Science 37 is a pioneering clinical research organization that focuses on decentralized clinical trials through its innovative Metasite model, which eliminates the need for physical proximity, allowing patients to engage in studies from virtually anywhere. This method significantly broadens accessibility, reaching over 90% of individuals who might be excluded from conventional site-based research, and harnesses the recruiting capabilities equivalent to 20 sites in one location, thereby offering patients the flexibility they desire. The Metasite operates on a proprietary platform that not only streamlines study orchestration but also facilitates the workflow for both patients and research staff, all while efficiently capturing study data without manual reentry. By centralizing personnel, processes, and technologies, this approach guarantees built-in protocol compliance, which leads to enhanced compliance rates and the collection of high-quality data. Science 37's dedicated in-house medical teams, telemedicine investigators, and mobile nursing professionals are well-versed in the conduct of remote trials spanning various therapeutic areas, thus ensuring comprehensive outreach. This commitment to innovative trial methodologies positions Science 37 at the forefront of transforming the landscape of clinical research.

Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.

The integration of eCOA and digital technologies is paving the way for the future of clinical research, seamlessly connecting traditional methods with innovative, patient-centered approaches. Choose YPrime's eCOA solutions to not only obtain high-quality patient data but also to enhance the overall user experience for sponsors, investigator sites, and patients alike. By employing a flexible software development strategy, YPrime is able to swiftly tailor and adapt functionalities to meet specific study requirements within an impressive timeframe of 8 to 12 weeks. Our engaging and visual design process allows clients to review the system at various stages of development, ensuring they are informed before the system goes live. Additionally, our pre-validated and customizable authoring environment not only streamlines startup timelines but also accommodates post-production adjustments, such as changes to study protocols, making it an indispensable asset for clinical research. This commitment to agility and responsiveness positions YPrime as a leader in the evolving landscape of clinical trials.

With more than two decades of expertise in the fields of software publishing and clinical research, Arone delivers a comprehensive array of tools designed for the efficient entry and management of patient data for clinical research organizations. Our solutions are ready to use, and we offer tailored support to ensure your projects and studies are conducted effectively. Utilize a unified platform to gather and oversee patient data seamlessly. Arone facilitates patient randomization by randomly designating treatment types to study participants, which helps eliminate bias in research outcomes. Enhance the engagement of clinical trial participants by enabling them to enter their daily data conveniently. Additionally, our personalized support enhances the overall success of your research projects. Together, we strive to innovate and improve the clinical research landscape.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

uMotif is an innovative platform for eCOA/ePRO and eConsent, aimed at enhancing both clinical and real-world research efforts. Created with input from patients, this platform offers unmatched engagement, significantly improving the speed, quality, and precision of data collection. Through the integration of uMotif's eCOA/ePRO system with real-time glucose monitoring, the platform achieved remarkable compliance rates during a comprehensive diabetes study across Europe. In another instance, an immunology trial benefited from the patient-focused eCOA/ePRO solution, enabling the sponsor to fulfill data requirements a full six months ahead of schedule. Additionally, in a CNS study mandated by the FDA, participants utilized their personal devices to provide submission-ready ePRO data, showcasing the platform's versatility. uMotif's commitment to a patient-first design philosophy emphasizes a deep understanding of the patient experience and the factors influencing their behavior. This expertise not only ensures the development of software that addresses patient needs effectively but also results in extraordinarily high engagement levels for study sponsors, fostering a win-win environment for both parties.

ClinSoft™, was developed in-house by Innovate Research. There were no third-party acquisitions and integrations. The system is compliant to FDA regulations (21 CFR Part 11, as well as GCP and HIPAA. The system is fully auditable and validated. ClinSoft™, which is easy to use, ensures quick start-ups and close-outs. This saves you precious time and allows you to be certain that any mid-study amendments or updates to protocols will be made promptly. Innovate Research, an Indian contract research company, provides services in clinical research and regulatory affairs. US FDA 21 CFR Part 11 compliant. Electronic Signatures & Records Secure, Role-Based Access. Audit Trail. Easy to use interface for Edit Checks and CRF Set-up. Frameworks that can be reused for item, panel, visit, and page.

Korio serves as a versatile platform for Randomization & Trial Supply Management (RTSM), emphasizing adaptability, high standards, and efficiency. It is engineered not merely to respond to the challenges of clinical trials but to proactively avert them from arising. Regardless of the trials encountered, Korio is equipped to manage them effectively. Traditional RTSM systems struggle to accommodate the growing complexity of study designs, and inflexible platforms fail to implement necessary RTSM design modifications swiftly in response to clinical trial adjustments. Drawing from extensive practical experience, Korio has created an RTSM solution where adaptability and dependability coexist, blending innovation with seasoned expertise. Enhance your operational efficiency through Korio's user-friendly, role-specific interface, which empowers a diverse range of users—from site personnel and supply managers to clinical operations and data management teams—to work more efficiently and confidently. With Korio, enjoy a consistently managed trial experience that can adapt to your evolving needs. Ultimately, Korio is not just a tool, but a comprehensive solution for modern clinical trial management.

Experience the forefront of eSource, CTMS, and eRegulatory software designed specifically for clinical trial sites. With CRIO’s top-tier electronic source, you can effortlessly capture source data in real-time, drastically cutting down on paper usage by up to 90% while enhancing data quality by 80%. Gain command over your operations through CRIO’s user-friendly Clinical Trial Management System, allowing you to efficiently schedule patients, monitor financials, and optimize recruiting processes. We proudly present cutting-edge electronic regulatory binders, including the innovative first-ever electronic delegation log, all compliant with 21 CFR Part 11 standards. For clinical trial sponsors, you can perform 100% remote monitoring of your sites’ source data and regulatory documents through a secure online portal. Become a part of our extensive network of over 500 clinical research sites worldwide. Our commitment is to facilitate the growth of your business by streamlining your site’s operations, ensuring that your studies can continue smoothly, regardless of whether you're on-site or not. This way, you can focus on what truly matters: advancing your clinical research initiatives.

Clinpal stands out as the premier comprehensive clinical research platform specifically designed for virtual, hybrid, and direct-to-patient studies. Patients can access the platform from any location using various devices, ensuring convenience and accessibility. Research teams can harness robust data and analytics throughout the entire duration of the trial, while sites benefit from having all necessary functionalities consolidated into one user-friendly system, thus alleviating their workload. With Clinpal Build, users can utilize an intuitive point-and-click interface that allows Contract Research Organizations (CROs) and others to swiftly and effortlessly define data, forms, and workflows. The platform's Single Platform feature offers complete support for clinical trials, encompassing everything from patient recruitment and data capture to long-term follow-up, with data readily available as needed. Clinpal’s cutting-edge technology is designed to accommodate multiple formats, providing a unified online configuration; by setting it up once, it seamlessly operates for users on browsers, mobile devices, or applications. This innovative approach ensures that researchers and participants alike can engage with clinical trials in a streamlined and efficient manner.

Effectively monitor clinical trials from start to finish with Ennov’s comprehensive Clinical Trial Management software. Each year, clinical trial sponsors search for new ways to improve the efficiency and reduce the costs associated with running their trials. Investigational site efficiency and productivity can be improved by centralizing information, actively monitoring progress, automating schedules, managing finances, and providing accurate reporting and metrics. With the Ennov CTMS, trial sponsors and CROs are able to actively address all aspects of trial management from a single platform: investigator sites, patients, SAEs, deviations, inclusions, visit reports, phone contacts, investigational product management, trial facilities, and finances. Study managers can plan and track their trials in real time to make better decisions faster. With the Ennov CTMS dashboard functionality, study personnel get on-demand analytics to improve quality, control risk, and reduce costs.